期刊文献+

2型糖尿病患者住院期间体重变化的临床分析 被引量:3

The clinical analysis of the weight changes in type 2 diabetes mellitus inpatients
原文传递
导出
摘要 目的通过观察2型糖尿病患者住院期间的体重变化情况,探讨其体重增加的危险因素。方法测定812例2型糖尿病患者入院次日及出院当天体重,并收集相关临床资料,对住院期间体重变化及相关因素进行统计分析。结果大部分2型糖尿病患者住院期间体重发生明显变化,其中体重增加者为54.1%,体重减少者为18.5%,27.4%体重无明显变化。与体重减轻组及体重不变组相比,体重增加组年龄较小(P〈0.05)、初诊断者及入院前体重下降者比例高(P均〈0.01)、体重减轻组使用百泌达比例较体重增加组和体重不变组明显升高(P〈0.01)。结论2型糖尿病住院期间体重变化是普遍现象,其中体重增加较为突出,且与年龄小、初诊断、使用胰岛素及入院前体重下降相关。 Objective To observe the weight changes of hospitalized patients with type 2 diabetes and explore the risk factors for weight gain. Methods Weights of 812 cases of diabetic inpatients were measured on the second day in hospital and the day of discharge. The clinical data were collected as well as the correlation between weight change and related clinical factors were analyzed. Results Most of the diabetic inpatients had a significant change in body weight,54.1% of them gained weight, 18.5% lost weight and 27.4% had no significant change. Compared with the control group( weight loss and no weight change group), the average age of the patients in weight gaining group was younger ( P 〈 0.05 ), the proportion of weight loss before admission and initial diagnosis were higher(P 〈 0.01 ). Besides, Byetta could significantly increase the proportion of patients losing weight(P 〈 0.01 ). Conclusion The change of body weight in diabetic inpatients is a common phenomenon, and the weight gain is more prominent which is related to age, initial diagnosis, using of insulin, and the weight loss before admission.
出处 《临床内科杂志》 CAS 2016年第5期327-329,共3页 Journal of Clinical Internal Medicine
关键词 2型糖尿病 住院患者 体重变化 危险因素 Type 2 diabetes Inpatient Weight change Risk factor
  • 相关文献

参考文献8

二级参考文献40

  • 1查冬青,吴小燕,徐联芳,贾汝汉.霉酚酸酯对2型糖尿病大鼠肾组织的保护作用[J].中国中西医结合肾病杂志,2006,7(5):263-266. 被引量:4
  • 2Sarafidis Pantelis A,Riehle Jessica,Bogojevic Zvezdana,et al.A compar-ative evaluation of various methods formicroalbuminuria.screening[J].Am J Nephrol,2008,28:324.
  • 3Shankar Munusamy,Hamida Saba,Tanecia Mitchell,etal.Alteration of renal respiratory complex-Ⅲduringexperimental type-1 diabetes[J].BMC EndocrineDisorders,2009,9:2.
  • 4A K H Lim,F Y Ma,D J Nikolic-Paterson,et al.Lymphocytes promote albuminuria,but not renaldysfunction or histological damage in a mouse model ofdiabetic renal injury[J].Diabetologia,2010(53):1772.
  • 5Cai Yu,Chen Jianwen,Jiang Jianmin,et al.Zhen-wu-tang,a blended traditional Chinese herbal medicine,ameliorates proteinuria and renal damage ofstreptozotocin-induced diabetic nephropathy in rats[J].J Ethnopharmacol,2010,131:88.
  • 6Akira Mima,Takeshi Matsubaral,Hidenori Arai,et al.AngiotensinⅡ-dependent Src and smad signalingpathway is crucial for the development of diabeticnephropathy[J].Laboratory Investigation,2006,86:927.
  • 7Mima A,Arai H,Matsubara T,et al.Urinary smad1 isa novel marker to predict later onset of mesangial matrixexpansion in diabetic nephropathy[J].Diabetes,2008,57:1712.
  • 8Purrello F, Rabuazza AM. Metabolic factors that affect beta-cell function and survival. J Diabetes Nutr Metab, 2000, 13: 84-91.
  • 9Sivitz WI. Lipotoxicity and glucotoxicity in type 2 diabetes. Effects on development and progression. J Postgrad Med, 2001, 109: 55-59,63-64.
  • 10Ilkova H, Glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed tyepe 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20: 1353-1356.

共引文献61

同被引文献12

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部